A group made up of third sector providers including Addaction, Blenheim, Cranstoun, CRI, Lifeline Project, Phoenix Futures, Swanswell and Turning Point have appointed Paul Hayes, to lead and develop the “Collective Voice” Project to ensure the voice of the drug and alcohol sector and those who uses its services are adequately heard.
The project will:
- Identify the most effective structures and mechanisms to enable the entire drug and alcohol treatment sector to represent the interests of its service users to relevant stakeholders;
and
- Establish how the drug and alcohol treatment sector can help the government achieve its ambition.
The intention is that structures developed by the project will over time draw in a wide range of third sector and NHS providers, and create alliances across other relevant sectors; mental health, criminal justice, housing etc. to identify issues of shared concern.
The project will be overseen by a Board made up of the funding organisations and will commence with immediate effect.
In making the appointment the Collective Voice Board said:
“Leadership of this project will require influencing skills, political astuteness and experience of building successful partnerships and links with key stakeholders at the highest level the board were clear that Paul Hayes was the outstanding applicant to provide this.”
For more information please contact:
John Jolly, CEO Blenheim [email protected] 020 7582 2200
Related Content
Collective Voice calls on Government to prioritise reducing harm from drugs
Every one of these deaths is a tragedy – and we should be doing more as a society to prevent them. ONS 2024 data on
Collective Voice responds to the Government’s consultation on the Autumn Budget
The Government has set out admirable ideas and principles in the 10-year health plan and the response to the Independent Sentencing Review, as well as
The Women’s Treatment Working Group launches its Womanifesto
Through dedicated spaces, support for mothers, and co-designed pathways, we can build a system that is safe, inclusive, and effective for all women. Read the